Oregon Health & Science University researchers have discovered a concerning trend in contraceptive access for patients despite legislation in 19 states mandating insurance coverage for a 12-month supply of contraception. The study, recently published in the journal JAMA Health Forum, highlights that patients are not receiving the full year’s worth of their prescription, with most only obtaining three months or less.
The study focused on short-acting hormonal contraception, such as the birth control pill, and revealed that the policies requiring coverage for a 12-month supply have not been fully enforced. This lack of implementation has not led to a significant increase in year-long prescription orders nationwide, leaving many patients at a heightened risk of unintended pregnancy.
One of the main reasons for decreased effectiveness with the pill is interruptions in usage, often caused by running out of a prescription or missing a refill. Dispensing a longer-term supply of contraception, either six or 12 months, has been proven to improve continuous use, reduce breaks in coverage, and result in cost savings for the healthcare system.
Dr. Maria Rodriguez, a professor of obstetrics and gynecology at OHSU, emphasized the importance of timely access to contraception, stating that decisions about pregnancy should not be hindered by delays in obtaining refills. To address this barrier, 19 states have enacted policies requiring insurers to cover the cost of dispensing a full year of contraception per prescription. However, the study found that these policies have not been fully implemented, leading to minimal changes in prescribing practices.
Using a difference-in-difference model, researchers analyzed contraception prescriptions among nearly 4.8 million female Medicaid enrollees aged 18 to 44 in 36 states, comparing outcomes in states with and without the 12-month supply policy. The results showed only a marginal increase in year-long prescription orders in states with the policy, indicating a significant gap in knowledge for both patients and prescribers.
Dr. Rodriguez stressed the need for comprehensive implementation of these policies, including increased awareness among contraceptive users, prescribers, pharmacists, and payers. She also highlighted the importance of enforcing compliance from insurance companies and advocating for a federal policy mandating coverage of a 12-month supply to ensure broad access to contraception.
Patients are encouraged to inquire about their contraceptive options and advocate for choices that align with their personal preferences, lifestyle, and family planning goals. By removing barriers and promoting access to contraception, healthcare providers can support patients in making informed decisions about their reproductive health.
For more information, the study conducted by Maria I. Rodriguez et al can be found in JAMA Health Forum (DOI: 10.1001/jamahealthforum.2024.2755). This research sheds light on the gaps in access to long-term contraceptive supplies and underscores the importance of improving contraceptive access for all individuals.
